3,4-dihydroxyphenylglycol has been researched along with Complications, Pregnancy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aklillu, E; Bertilsson, L; Heikkinen, T; Hilli, J; Kishida, I; Laine, K; Lehtimäki, T; Rontu, R; Vahlberg, T | 1 |
Berlin, I; Georgieu, S; Heilbronner, C; Launay, JM; Meier, C; Spreux-Varoquaux, O | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylglycol and Complications, Pregnancy
Article | Year |
---|---|
MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs.
Topics: Catechol O-Methyltransferase; Child; Child, Preschool; Cytochrome P-450 Enzyme System; Depression; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Polymorphism, Genetic; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prolactin; Prospective Studies; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Syndrome; Statistics, Nonparametric | 2009 |
Reduced monoamine oxidase A activity in pregnant smokers and in their newborns.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Cotinine; Female; Fetal Blood; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant, Newborn; Maternal-Fetal Exchange; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Norepinephrine; Parturition; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Tobacco Use Disorder | 2009 |